Zimmer Biomet reports top- and bottom-line growth as orthopedic procedures return

Buoyed by sales of knee and hip replacements and improving procedure rates, Zimmer Biomet started the year with a “phenomenal quarter where pretty much everything went better than expected,” CEO Bryan Hanson said on a Tuesday earnings call.